A Study of XW003 Injection in Chinese Adolescents With Obesity

Phase 1 Completed 48 enrolled Hangzhou Sciwind Biosciences Co., Ltd.

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity

Timeline

Start: 2025-08-25
Primary completion: 2026-04-18
Completion: 2026-04-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ecnoglutide	Protein / enzyme biologic	—	Subcutaneous

A Study of XW003 Injection in Chinese Adolescents With Obesity

Summary

Timeline

Drugs

Indications